Skip to main content
OpenTrials
Completed

NCT Number: NCT02426554

Dietary Supplementation of of DHA, Vitamin D3 and Uridine in Children

The feasibility of combining a motor and cognitive exercise program with dietary supplementation (DDU: Vitamin D, DHA and Uridine or Placebo) is tested in a smaller group of prepubescent children.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Age range

8 year–11 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • age 8 to 11 yrs.

Exclusion criteria

  • history of neurological or psychiatric disorders.

Treatment and study plan

DDU-supplement

Dietary Supplement

DDU: Vitamin D, DHA, Uridine

Placebo supplement

Dietary Supplement

Primary outcomes

  1. Compliance to cognitive and motor training program (Move It To Improve It: MiTii)

    Time frame: 6 weeks

    Internet based program with evaluation of numbers of training sessions. At least 14 training sessions out of 18 should be completed.

  2. Dietary compliance

    Time frame: 6 weeks

    Supplement was provided to the children and ingestion was registered by the parents.

Sponsors and collaborators

Lead sponsor

University of Copenhagen

Other

Collaborators

  • Helene Elsass Center, Denmark.
  • Technical University of Denmark

Registry information

Important dates

Study start
2011
Primary completion
2011
Study completion
2011
First posted
Apr 27, 2015
Registry last updated
Aug 3, 2016

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.